Perrigo (PRGO) Moves 6.1% Higher: Will This Strength Last?
Maravai LifeSciences Holdings Inc MRVI
$7.60
▼ -0.65%
($-0.05)
Open
$7.61
Prev Close
$7.65
Day Range
$7.25 – $7.65
52W Range
$2.55 – $9.42
Market Cap
$1.97B
Beta
0.61
EPS (TTM)
$-0.53
📋 Company Profile
| Industry | Life Sciences Tools & Services |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2020-11-20 |
| Shares Out. | 258,190,000 |
| Website | maravai.com/ ↗ |
| Phone | 13026587581 |
| Employees | 415 |
| Revenue | $51.4M |
| Gross Profit | $20.7M |
| Net Income | -$21.6M |
| Free Cash Flow | -$35.1M |
| Total Assets | $603.7M |
| Total Liabilities | $248.2M |
| Equity | $355.6M |
About Maravai LifeSciences Holdings Inc
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
Maravai LifeSciences Holdings Inc is a publicly traded company under the ticker symbol MRVI on the NASDAQ NMS - GLOBAL MARKET, operating in the Life Sciences Tools & Services industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
15 analysts (2026-09-01)